Tuesday 12/9/2014 Fast Moving Stocks (CTIX) (NTEK) (FNMA) (TRTC) (PPHM)

We hope all of our readers and visitors are having a profitable Tuesday. As always, we must start off with one of the day’s biggest movers, Cellceutix Corporation (CTIX). So far today CTIX has traded over 2723411 shares, slightly above its 30 day average volume. The stock opened at 4.51 this morning, trading with a market cap of $536.91M. CTIX is now sitting at 4.7 as we type this. The latest press release from CTIX is: Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA. Investors will surely be watching CTIX over the next few days.

Another fast moving stock is NanoTech Entertainment, Inc. (NTEK). As we monitor NTEK, we’ve watched over 1354235 shares trade today, which is below its 30 day average volume. The stock is trading with a market cap of $23.35M. The last PR traders have seen from NTEK reads: Are These Tech Stocks On Your Pre-Thanksgiving Menu?¬†Federal National Mortgage Association (FNMA) has also caught the attention of daytraders today. FNMA is currently trading at 2.35, which puts the company’s value at $13.49B. So far the stock has traded 5452803 shares, slightly under its 30 day average volume of 15795100.

Pull up the chart on TRTC and you will see why it deserves its spot in the media. Currently priced at about 0.31 per share, Terra Tech Corp. (TRTC) has traded over 1100990 shares today, slightly below its 30 day average volume of about 1875150. The stock opened around 0.33 this morning, bringing TRTC’s market capitalization to $58.92M. The latest press release from TRTC is Terra Tech Gives Update on Nevada Medical Cannabis Initiatives. We will be sure to watch TRTC closely over the next week.

Lastly, we must take a look at what happened to Peregrine Pharmaceuticals, Inc. (PPHM) today. PPHM has traded over 860071 shares today and is currently trading at 1.46. The stock opened around 1.33 this morning. Investors will surely be watching PPHM closely over the next few days.

___________________________________________________________________________________

Relevant Headlines:

Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA

Are These Tech Stocks On Your Pre-Thanksgiving Menu?

National Housing Survey Results Mirror Uneven 2014 Activity, Support
Forecast for Gradual Recovery in 2015

Terra Tech Gives Update on Nevada Medical Cannabis Initiatives

Peregrine Pharmaceuticals to Report Second Quarter Fiscal 2015 Financial Results After Market on December 10, 2014

___________________________________________________________________________________

About www.actualgains.com: We send you custom, well-thought-out penny stock profiles right to your inbox free of charge. We are one of the only penny stock newsletters who wait carefully before sending timely alerts. We examine technical analysis of penny stocks and huge market moves that could profit investors(like the current medical marijuana penny stock rally!) Subscribe free today. Do not miss our next report.

Disclaimer: This is not an offer to buy or sell securities. Information or opinions are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Neither ActualGains.com nor any of its employees, affiliates, subsidiaries or family members are registered investment advisors or registered stock brokers and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site. Do not buy any stock ActualGains.com mentions. We are not liable for any investment decisions by our readers. By way of visit to this webpage, you agree to indemnify and hold harmless ActualGains.com, its employees and owners against any and all actions, claims, damages, obligations, losses, proceedings, expenses and liabilities.